Investor Documents & Presentations
Annual Report & Accounts
General meeting documents
Results Presentations
Other Company Presentations
- Director’s talk interview: ‘Avacta Group make significant progress with its highly scalable lateral flow test’
- Alastair Smith gives SARS-CoV-2 Rapid Antigen Test video update
- How diagnostic test performance is measured
- Alastair Smith presents in Virtual Biotech Forum webinar
- Placing Presentation June 2020
- How a Lateral Flow Rapid Test Works
- Avacta CEO Alastair Smith provides update on COVID-19 collaboration with Cytiva
- Alastair Smith provides overview of pre|CISION™ prodrug technology and update on AVA6000 clinical trial
- Alastair Smith provides update on AffyXell collaboration and licence agreement
- Alastair Smith provides update on TMAC programme
- An Investor’s Introduction to pre|CISION Chemotherapies
- Corporate Presentation (Therapeutics) Feb 2020
- Joint venture between Avacta and Daewoong
- See more company presentations
Research Notes
Other documents